Drug company Apotex signs deal to buy Montreal-based Searchlight PharmaDisney Investors Look Beyond Board Battle as ‘Cheap’ Stock SoarsSenegal’s Bassirou Diomaye Faye Is Sworn In as New PresidentOil Near Five-Month High on Middle East Risks, Mexico Supply CutIran Says Sent US Message Over Deadly Israeli Strike on CompoundSteelmaker SSAB to Invest €4.
2 Billion to Spur GrowthTrump Gag Order Expanded by NY Judge Before Hush-Money TrialColombia Central Bank Cites Politics in ‘Cautious’ Key Rate CutFidelity-Backed Fintech Targets 30% Growth, $1 Billion RevenueDisney Investors Look Beyond Board Battle as ‘Cheap’ Stock SoarsTananbaum’s GoldenTree Sells Crypto Subsidiary to RepublicDrones Strike Russia’s Tatarstan Region, Far From Ukraine BorderExtreme Heat Shuts Philippine Schools, Prompts Remote ClassesOwner of Crypto Platform CoinSwitch...
Source: News Formal (newsformal.com)
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
China’s Drug Stocks Surge on Innovative Drug Support SpeculationChinese pharmaceutical stocks rose amid speculation that authorities are working on a plan to support the development of world-leading innovative drugs.
Source: BNNBloomberg - 🏆 83. / 50 Read more »
Kobayashi Pharma Extends Drop on Report a User of Its Pills DiedShares of Japanese drugmaker Kobayashi Pharmaceutical Co. extended Monday’s slump after the company said it received a report one of the users of its recalled supplement pills died due to kidney disease.
Source: BNNBloomberg - 🏆 83. / 50 Read more »
Novo Nordisk Agrees to Buy Cardior Pharma for Up to €1 BillionNovo Nordisk A/S agreed to buy Cardior Pharmaceuticals for up to €1 billion ($1.1 billion) as the Danish maker of weight-loss drugs continues to expand into treatments for cardiovascular disease.
Source: BNNBloomberg - 🏆 83. / 50 Read more »
IFF to sell pharma unit to Roquette for enterprise value of $2.85-billionThe move comes at a time when International Flavors & Fragrances is seeing demand slow for its food ingredients and solutions business
Source: globebusiness - 🏆 31. / 66 Read more »
AstraZeneca to buy Fusion Pharma for $2 billion in cashThe drugmaker will pay $21 per Fusion share, a premium of more than 97% to the U.S.-listed company's closing price on Monday. AstraZeneca will also pay a...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »
AstraZeneca to buy Amolyt Pharma for US$1.05-billion to boost rare-disease portfolioThe deal, which includes an $800-million upfront payment and an additional contingent payment of $250-million on achieving a specified regulatory milestone, is expected to close by the third quarter of 2024
Source: globeandmail - 🏆 5. / 92 Read more »